epa glp 1 GLP-1 drugs may help extremely obese patients qualify for weight-loss surgery GLP-1 Support Supplements | Muscle,

Glucagon-like peptide-1 (GLP-1) is an incretin known for its anti-obesity effects, and several effective drugs targeting GLP-1 receptors (GLP-1Rs) have recently been developed to treat obesity

We take a look at the clinical trial results that suggests it can.

Currently, there are more than 1 billion people worldwide with obesity, many of whom also have type 2 diabetes mellitus or prediabetes

Personalized diet and exercise interventions, alongside pharmacological treatments, are crucial for enhancing both metabolic and psychological outcomes, ensuring a more sustainable and effective approach to managing obesity

JAMA Psychiatry article:Repurposing Semaglutide and Liraglutide

Most people taking a 1,250 version wont even know they need to tell their doctor